Want to share this?

AI promises meaningful advances in healthcare. From helping patients understand symptoms and treatment options to synthesizing insights from electronic medical records, AI tools like ChatGPT Health aim to make health information more accessible, personalized, and convenient. But this promise comes with a crucial caveat: AI’s potential for good can also amplify risk when governance, privacy, and safety aren’t at the forefront.

The launch of ChatGPT Health highlights this tension. On the one hand, the tool builds on strong privacy and security foundations, offering enhanced encryption, compartmentalized data handling, and optional integration with personal records and wellness apps. On the other hand, it raises distinct privacy, regulatory, and safety concerns that organizations and individuals alike must take seriously. 

Enhanced Privacy Protections Don’t Eliminate Risk

OpenAI has positioned ChatGPT Health as a secure environment. Conversations are encrypted in transit and at rest. The health tab is segregated from general ChatGPT interactions and uses additional layers of purpose-built encryption and isolation to protect sensitive data. Users are encouraged to enable multifactor authentication and retain full control over linked applications and records. 

These measures represent meaningful progress compared with general-purpose AI tools. They reflect an awareness that health data is inherently more sensitive and governed by stricter expectations than most other types of information.

However, enhanced privacy architecture does not automatically equate to full compliance with healthcare-specific laws or protections. ChatGPT Health is not regulated as a medical device, nor is it covered by HIPAA solely because it is a consumer tool—a distinction that has unsettled many clinicians and privacy experts. 

This means that while encrypted storage and compartmentalized data handling are strong technical safeguards, regulatory gaps remain. Without explicit oversight from healthcare regulators, there are no mandatory safety protocols, risk reporting requirements, or independent post-market surveillance of how the system performs in real-world use. 

Accuracy, Misuse, and the Risk of Harm

AI in healthcare isn’t only about privacy. The risk of inaccurate guidance or harmful information is real. Experts have raised concerns that AI responses may prioritize helpfulness over medical accuracy, potentially leading users astray. Cases have already emerged of unregulated AI health advice leading to harmful outcomes when users acted on incorrect information. 

Unlike regulated medical software, ChatGPT-based health tools are not subject to clinical trials, mandatory accuracy thresholds, or standardized safety evaluations. This gap makes governance frameworks, independent testing, and transparent risk communication essential for organizations that integrate these tools into patient engagement strategies or clinical workflows.

Consent, Transparency, and Data Use

Linking medical records and wellness apps to AI tools introduces another set of governance challenges:

  • What are users told about how their data will be used?
  • How are consent and revocation managed?
  • What happens to data in the event of a breach or if a legal request is made?

Even with default protections in place, these questions strike at the heart of trust and control. When individuals connect sensitive health data, governance must ensure informed consent is meaningful, not just a checkbox buried in a privacy policy.

The Regulatory Frontier Isn’t Settled

Healthcare has long been a highly regulated space. But AI is moving faster than many regulatory frameworks, leaving a period of uncertainty. Some jurisdictions have yet to define exactly how consumer-facing health AI will be governed, and existing medical data laws may not clearly apply outside clinical contexts.

This emerging regulatory ambiguity underscores the need for organizations to adopt governance structures that go beyond compliance with current rules and anticipate future standards.

Governance as a Cornerstone of Responsible AI in Health

Organizations and individuals alike must recognize that AI’s benefits in healthcare come with proportional risk. Privacy protections and technical safeguards are necessary but not sufficient on their own.

A strong AI governance approach in health use cases should include:

  • Clear risk assessments that go beyond technical security to include accuracy, fairness, and clinical impact
  • Transparency and consent practices that ensure users understand how data is used and protected
  • Ongoing monitoring to detect and mitigate issues such as misinformation, bias, and unexpected behavior
  • Defined accountability and escalation pathways when harm occurs or when regulatory questions arise

When governance and innovation are aligned, AI can enable safer, more responsible healthcare engagement without sacrificing the opportunities it brings.